For the safety of our patients and staff, we have updated our visitor policy, effective December 27. This includes important information about COVID-19 vaccination or testing for some visitors. Read the latest information for visitors.
Development of KB004, a Therapeutic Antibody Targeting EphA3 in Solid and Hematopoietic Cancers
Tea will be served at 1:45 pm.
This program is for the research community.
Date & Time(s)
Memorial Sloan Kettering Cancer Center
Rockefeller Research Laboratories
430 East 67th Street
New York, NY 10065